247 related articles for article (PubMed ID: 26447967)
1. Probiotics in Irritable Bowel Syndrome: The Science and the Evidence.
Quigley EM
J Clin Gastroenterol; 2015; 49 Suppl 1():S60-4. PubMed ID: 26447967
[TBL] [Abstract][Full Text] [Related]
2. Irritable bowel syndrome: a concise review of current treatment concepts.
Wall GC; Bryant GA; Bottenberg MM; Maki ED; Miesner AR
World J Gastroenterol; 2014 Jul; 20(27):8796-806. PubMed ID: 25083054
[TBL] [Abstract][Full Text] [Related]
3. A nutritional approach for managing irritable bowel syndrome.
Bhesania N; Cresci GAM
Curr Opin Pediatr; 2017 Oct; 29(5):584-591. PubMed ID: 28737582
[TBL] [Abstract][Full Text] [Related]
4. Gas chromatography/mass spectrometry based metabolomic study in a murine model of irritable bowel syndrome.
Yu LM; Zhao KJ; Wang SS; Wang X; Lu B
World J Gastroenterol; 2018 Feb; 24(8):894-904. PubMed ID: 29491683
[TBL] [Abstract][Full Text] [Related]
5. The Role of Bovine Kappa-Casein Glycomacropeptide in Modulating the Microbiome and Inflammatory Responses of Irritable Bowel Syndrome.
Qu Y; Park SH; Dallas DC
Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764775
[TBL] [Abstract][Full Text] [Related]
6. The Role of Nutraceutical Supplements in the Treatment of Irritable Bowel Syndrome: A Mini Review.
Wal A; Srivastava A; Verma N; Pandey SS; Tyagi S
Curr Pediatr Rev; 2024; 20(1):66-75. PubMed ID: 36593535
[TBL] [Abstract][Full Text] [Related]
7. Histamine-producing bacteria and their role in gastrointestinal disorders.
Fiorani M; Del Vecchio LE; Dargenio P; Kaitsas F; Rozera T; Porcari S; Gasbarrini A; Cammarota G; Ianiro G
Expert Rev Gastroenterol Hepatol; 2023; 17(7):709-718. PubMed ID: 37394958
[TBL] [Abstract][Full Text] [Related]
8. Multi-Strain Probiotics: Synergy among Isolates Enhances Biological Activities.
Kwoji ID; Aiyegoro OA; Okpeku M; Adeleke MA
Biology (Basel); 2021 Apr; 10(4):. PubMed ID: 33924344
[TBL] [Abstract][Full Text] [Related]
9. Applications of Probiotics and Their Potential Health Benefits.
Fuochi V; Furneri PM
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958897
[TBL] [Abstract][Full Text] [Related]
10. Authors' reply to letter: He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome.
Mullish BH; Michael DR; Dabcheva M; Webberley TS; Coates N; John DA; Wang D; Luo Y; Plummer SF; Marchesi JR
Neurogastroenterol Motil; 2024 May; ():e14820. PubMed ID: 38764218
[No Abstract] [Full Text] [Related]
11. Mechanism of Action Considerations in the Management of IBS-C.
Brenner DM
Gastroenterol Hepatol (N Y); 2023 Dec; 19(12):749-756. PubMed ID: 38404415
[No Abstract] [Full Text] [Related]
12. New and Emerging Treatment Options for Irritable Bowel Syndrome.
Lacy BE; Chey WD; Lembo AJ
Gastroenterol Hepatol (N Y); 2015 Apr; 11(4 Suppl 2):1-19. PubMed ID: 26491416
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
Distrutti E; Monaldi L; Ricci P; Fiorucci S
World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome.
Thijssen AY; Clemens CH; Vankerckhoven V; Goossens H; Jonkers DM; Masclee AA
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):8-14. PubMed ID: 26469356
[TBL] [Abstract][Full Text] [Related]
15. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.
Staudacher HM; Whelan K
Proc Nutr Soc; 2016 Aug; 75(3):306-18. PubMed ID: 26908093
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for Probiotic Use--2015 Update: Proceedings and Consensus Opinion.
Floch MH; Walker WA; Sanders ME; Nieuwdorp M; Kim AS; Brenner DA; Qamar AA; Miloh TA; Guarino A; Guslandi M; Dieleman LA; Ringel Y; Quigley EM; Brandt LJ
J Clin Gastroenterol; 2015; 49 Suppl 1():S69-73. PubMed ID: 26447969
[TBL] [Abstract][Full Text] [Related]
17. Probiotics for Irritable Bowel Syndrome: Clinical Data in Children.
Giannetti E; Staiano A
J Pediatr Gastroenterol Nutr; 2016 Jul; 63 Suppl 1():S25-6. PubMed ID: 27380595
[TBL] [Abstract][Full Text] [Related]
18. Probiotics in functional bowel disorders.
Hod K; Ringel Y
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):89-97. PubMed ID: 27048900
[TBL] [Abstract][Full Text] [Related]
19. THE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a review.
Moraes-Filho JP; Quigley EM
Arq Gastroenterol; 2015 Dec; 52(4):331-8. PubMed ID: 26840477
[TBL] [Abstract][Full Text] [Related]
20. Probiotics in digestive diseases: focus on Lactobacillus GG.
Pace F; Pace M; Quartarone G
Minerva Gastroenterol Dietol; 2015 Dec; 61(4):273-92. PubMed ID: 26657927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
